Article Details

Horizon Therapeutics to Expand Pipeline, R&D with $3B Viela Bio Acquisition

Retrieved on: 2021-02-01 16:30:00

Tags for this article:

Click the tags to see associated articles and topics

Horizon Therapeutics to Expand Pipeline, R&D with $3B Viela Bio Acquisition. View article details on hiswai:

Excerpt

Horizon identified Citigroup Global Markets and Morgan Stanley Senior Funding as the sources of the fully committed financing that it has put in place ...

Article found on: www.genengnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo